Many small-molecule antibiotics achieve their antibacterial effects by targeting intracellular processes essential for bacterial survival. Clinically important key examples include quinolones and tetracyclines, which inhibit DNA and protein synthesis . Some AMPs, such as indolicidin and thiopeptides, also disrupt these intracellular pathways . This section discusses the mechanisms and therapeutic potential of these AMPs.